Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian... Read more.
Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
DALLAS, Oct. 13, 2025 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic... Read more.
Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
First published data from a multicenter retrospective chart review study to explore the safety and efficacy of pyrimidine nucleoside and/or nucleotide therapy in... Read more.
Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
15 out of 18 complete responders (83%) demonstrate continued complete response with median follow-up of 36 months Reduction in surgeries compared to year prior to... Read more.
Pelican Provides Advanced Protective Cases for Next Generation Squad Weapons at AUSA 2025
Protecting the U.S. Military’s NGSW Program with Mission-Ready Protective Transit Solutions TORRANCE, Calif., Oct. 13, 2025 /PRNewswire/ — Pelican Products,... Read more.
NetActuate Supports Raleigh-Durham-Chapel Hill Triangle with Investments in Technology Access and Education
RALEIGH, N.C., Oct. 13, 2025 /PRNewswire/ — NetActuate, a global provider of network and infrastructure services, is proud to reaffirm its commitment to the... Read more.
Level Education Group Acquires Triad to Transform the Educational and Professional Pathway for Behavioral and Mental Health Professionals
SOUTH JORDAN, Utah, Oct. 13, 2025 /PRNewswire/ — Level Education Group, LLC (“LEG”), a leader in continuing education for mental health and nursing... Read more.
Shield AI and Parry Labs Announce Strategic Collaboration to Deliver Integrated Autonomy at the Edge
WASHINGTON, Oct. 13, 2025 /PRNewswire/ — Shield AI and Parry Labs today announced a Memorandum of Understanding (MoU) to integrate advanced autonomy with edge... Read more.
StoryOne: Human-Centric AI Publishing launches ahead of Frankfurt Book Fair 2025
VIENNA, Oct. 13, 2025 /PRNewswire/ — Next Wednesday (October 15) marks the official start of the Frankfurt Book Fair – and the Vienna-based start-up StoryOne... Read more.
Vertiv Names Craig Chamberlin as Chief Financial Officer
COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ — Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today announced the appointment... Read more.